Abstract | PURPOSE: METHODS: Tissue microarrays consisting of 305 cases of breast invasive ductal carcinoma were used for immunohistochemical evaluation of PHGDH expression. The role of PHGDH in breast cancer was investigated in vitro by knocking down its expression and determining the effect on cell proliferation and cell cycling, and in ovo by using a chorioallantoic membrane (CAM) assay. RESULTS: Immunohistochemical examination showed that PHGDH is mainly localized in the cytoplasm of breast cancer cells and significantly associated with higher cancer grade, larger tumor size, increased PCNA expression, and lymph node positivity. Analysis of the GOBO dataset of 737 patients demonstrated that increased PHGDH expression was associated with poorer overall survival. Knockdown of PHGDH expression in breast cancer cells in vitro resulted in a decrease in cell proliferation, reduction in cells entering the S phase of the cell cycle, and downregulation of various cell cycle regulatory genes. The volume of breast tumor in an in ovo CAM assay was found to be smaller when PHGDH was silenced. CONCLUSION: The findings suggest that PHGDH has a regulatory role in breast cancer cell proliferation and may be a potential prognostic marker and therapeutic target in breast cancer.
|
Authors | Muthukrishnan Chandrika, Pei Jou Chua, Umamaheswari Muniasamy, Ruby Yun Ju Huang, Aye Aye Thike, Cheng Teng Ng, Puay Hoon Tan, George W Yip, Boon Huat Bay |
Journal | Breast cancer research and treatment
(Breast Cancer Res Treat)
Vol. 186
Issue 3
Pg. 655-665
(Apr 2021)
ISSN: 1573-7217 [Electronic] Netherlands |
PMID | 33625616
(Publication Type: Journal Article)
|
Chemical References |
- Serine
- Phosphoglycerate Dehydrogenase
|
Topics |
- Breast Neoplasms
(genetics)
- Cell Line, Tumor
- Cell Proliferation
- Female
- Humans
- Phosphoglycerate Dehydrogenase
(genetics)
- Prognosis
- Serine
|